Breast cancer patients in New Zealand plan march to plea for drug funding

Patients with advanced breast cancer and their families and friends are planning a march on New Zealand’s Parliament to ask Pharmac, an area pharmaceutical company, to fund two drugs they say could potentially provide some relief.

The two drugs in question, palbociclib and T-DM1, are only available in New Zealand “privately and at significant cost,” according to a report from Stuff Limited. The marchers will be delivering petitions that ask for both to be funded

“All I want is time,” Nicki Ball, an advanced breast cancer patient, told Stuff Limited. “It doesn't mean that I'm dying right now...It's just my horizon is sitting right at the tip of my toes. You guys just pretend it's not there.”

Click below to read the full story.

Michael Walter
Michael Walter, Managing Editor

Michael has more than 18 years of experience as a professional writer and editor. He has written at length about cardiology, radiology, artificial intelligence and other key healthcare topics.

Around the web

The nuclear imaging isotope shortage of molybdenum-99 may be over now that the sidelined reactor is restarting. ASNC's president says PET and new SPECT technologies helped cardiac imaging labs better weather the storm.

CMS has more than doubled the CCTA payment rate from $175 to $357.13. The move, expected to have a significant impact on the utilization of cardiac CT, received immediate praise from imaging specialists.

The all-in-one Omni Legend PET/CT scanner is now being manufactured in a new production facility in Waukesha, Wisconsin.